ArticleEuropean journal of nuclear medicine and molecular imaging2021
Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03329274 (Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses), which is not on this map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
Who cites it
13 citing papers in PubMed, 24 citations in OpenAlex.
- Diagnostic impact of 18F-FDG PET/MRI over PET/CT in histiocytoses: a prospective comparative study.European journal of nuclear medicine and molecular imaging · 2026Article
- Visualizing extracellular vesicles in cancer: from biogenesis to theranostic applications.Journal of nanobiotechnology · 2026Review
- RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition.Cancer cell · 2026Article
- Disease response criteria in Langerhans cell histiocytosis: a global view.International journal of hematology · 2025Review
- Case Report: When an unknown fever unmasks Erdheim-Chester disease: a case showing the use of multimodality imaging and the successful interferon alpha therapy.F1000Research · 2025Article
- Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.British journal of haematology · 2024Article
- Overview of F18-FDG uptake patterns in retroperitoneal pathologies: imaging findings, pitfalls, and artifacts.Abdominal radiology (New York) · 2024Review
- Erdheim-Chester disease with tendon and muscle involvement: Reports of a rare presentation.Radiology case reports · 2024Article
- Erdheim-Chester Disease Occult on Radiographs and CT but Visible on MRI and PET.The American journal of case reports · 2024Article
- Radiological findings in Erdheim Chester disease: A very rare multisistemic disease.Radiology case reports · 2023Article
- Targeted therapy monitoring of BRAF-V600-mutant Erdheim-Chester disease by fast quantitative whole-body bone CZT-tomoscintigraphies.European journal of hybrid imaging · 2023Article
- Multimodality imaging of spleen involvement in Erdheim-Chester disease mimicking splenic hemangioma: a unique case report.American journal of nuclear medicine and molecular imaging · 2023Article
- Utility of Fluorine-18-Labeled Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Diagnosis of Erdheim-Chester Disease with Multisystemic Involvement.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, IndiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 2 countries.
Funding
Abstract
objectivesThe aim of this study was to [1] characterize distribution of Erdheim-Chester Disease (ECD) by
methods
resultsFifty patients were included (mean age 51.5 years; range 18-70 years). Three hundred thirty-three disease sites were detected among all imaging modalities, 188 (56%) by both
conclusionCompared with anatomic imaging,
trial registrationClinicalTrials.gov Identifier: NCT03329274.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.